JPRN-UMIN000015587已完成2 期
Clinical trial with NaPPS for HTLV-1-associated myelopathy (HAM) patients - Clinical trial with NaPPS for HAM patients
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) The person having serious complications (2) The person who received a surgical treatment within six months before clinical trial. (3) The person whose prothrombin time and the activated partial thromboplastin time is out of the inspection standard value range at the time of the screening. (4) The person who has hemorrhagic factor; with a gastric ulcer and a duodenal ulcer and gastrointestinal bleeding doubted. The person with thrombocytopenia. The person who takes anticoagulant, antiplatelet and thrombolytic medications except aspirin. (5) The person who participated in other clinical studies or a clinical trial within four months before agreement acquisition (6) The person who takes vitamin K (7) The person of the keloid constitution (8) The person with past history of drug hypersensitivity or thrombocytopenia (9) The person of alcoholism or drug dependency (10) The person who has possibility of pregnancy. (11) In addition, the person that a\the clinical trial responsibility doctor or the clinical trial allotment doctor judged the participation in this clinical trial to be inadequate
研究者
相似试验
已完成
2 期
Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)Carcinoma of Unknown Primary SitesJPRN-UMIN000001364Kyushu Medical Oncology Group38
未知
1 期
Clinical trial for effectiveness and safety of WT1 peptide-pulsed allogeneic dendritic cell therapy for childhood patients with chemotherapy-resistant leukemia.pediatric leukemiaJPRN-UMIN000002105Department of Pediatrics, Shinshu University School of Medicine3
尚未招募
1 期
Vaccine HER1 / VSSP for prostate cancer, head and neck carcinoma and advanced colon cancer . Phase IColorectal Neoplasmshormonal castration-resistant prostate cancer, squamous cell carcinoma of the head and neck, and advanced colon cancerNeoplasms, Glandular and EpithelialNeoplasms, Squamous CellCarcinomaDigestive System DiseasesGastrointestinal DiseasesIntestinal DiseasesColonic DiseasesDigestive System NeoplasmsGastrointestinal NeoplasmsIntestinal NeoplasmsMale Urogenital DiseasesGenital Diseases, MaleProstatic DiseasesUrogenital NeoplasmsGenital Neoplasms, MaleCarcinoma, Squamous CellHead and Neck NeoplasmsColonic NeoplasmsProstatic Neoplasms, Castration-ResistantProstatic NeoplasmsRPCEC00000258Center of Molecular Immunology (CIM)120
已完成
1 期
Phase I trial of S-1 plus Lapatinib in patients with HER-2 positive metastatic breast cancerbreast cancerJPRN-UMIN000004921Tokai University School of Medicine6
进行中（未招募）
1 期
Phase I/II trial for vaccine therapy with hTERT-, survivin- and tumor cell derived mRNA + ex vivo T cell expansion and reinfusion in patients with metastatic malignant melanomaEUCTR2008-006253-41-NOThe Norwegian Radium Hospital, Oslo University Hospital25